Moleculin Biotech (MOL) Q4 2024 Earnings Report
DE:MOL Q4 2024 EPS Results
- Actual EPS
- EUR 111.92
- Consensus EPS
- -EUR 574.55
- Beat/Miss
- Beat by +EUR 686.47
- One Year Ago EPS
- -EUR 2,247.45
DE:MOL Q4 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/24/2025
- Time
- Before Open
- Conference Call
- Monday, March 24, 2025
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:MOL Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.37 | 88.57% (+194.30) | |
| May 15, 2026 | 2026 (Q1) | -41.79-63.39 | -308.91 | 79.48% (+245.52) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4846.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.24 | -63.8 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.51-219.37 | -761.09 | 71.18% (+541.72) | |
| May 14, 2025 | 2025 (Q1) | -248.47-308.91 | -904.35 | 65.84% (+595.44) | |
| Mar 24, 2025 | 2024 (Q4) | -574.55111.92 | -2247.45 | 104.98% (+2359.37) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.39-1275.94 | -1275.94 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.72-761.09 | -1343.1 | 43.33% (+582.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
